The dysregulation of the PI3K/Akt/FOXO3a axis may lead to drug resistance by enhancing DNA repair, as well as cancer cell maintenance, proliferation and survival through overexpression of FOXM1 [196, 202]. This evidence concerns the gene AKT1 and cancer.